Basic Information
RNALocate ID: RLID:01001594
RNA Symbol: hsa-miR-139-5p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-139-5p
RNA ID: miRBase:MIMAT0000250
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21637849
Tissue/Cell Line: Skeletal muscle myoblasts
Method: ISH|qRT-PCR
Description: List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11001358 Exosome Plasma 29323722
RLID:11001359 Exosome Plasma 23663360
RLID:11001360 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000044 Exosome Blood
RLID-D:11000313 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-139-5p Diffuse large b cell lymphoma MNDR-E-MI-13088
MNDR hsa-miR-139-5p Splenic marginal zone lymphoma MNDR-E-MI-13089
MNDR hsa-miR-139-5p Multiple sclerosis chronic progressive MNDR-E-MI-13090
MNDR hsa-miR-139-5p Oral squamous cell carcinoma MNDR-E-MI-13091
MNDR hsa-miR-139-5p Large cell neuroendocrine cancer MNDR-E-MI-13092
MNDR hsa-miR-139-5p Follicular lymphoma MNDR-E-MI-13093
MNDR hsa-miR-139-5p Medulloblastoma MNDR-E-MI-13094
MNDR hsa-miR-139-5p Uterine corpus endometrial carcinoma MNDR-E-MI-13095
MNDR hsa-miR-139-5p Lymphoma MNDR-E-MI-13096
MNDR hsa-miR-139-5p Lymphoma non-hodgkin MNDR-E-MI-13097
MNDR hsa-miR-139-5p Estrogen-receptor positive breast cancer MNDR-E-MI-13098
MNDR hsa-miR-139-5p Estrogen-receptor negative breast cancer MNDR-E-MI-13099
MNDR hsa-miR-139-5p Progesterone-receptor positive breast cancer MNDR-E-MI-13100
MNDR hsa-miR-139-5p Progesterone-receptor negative breast cancer MNDR-E-MI-13101
MNDR hsa-miR-139-5p Her2-receptor positive breast cancer MNDR-E-MI-13102
MNDR hsa-miR-139-5p Breast cancer luminal MNDR-E-MI-13103
MNDR hsa-miR-139-5p Prostate cancer MNDR-E-MI-13104
MNDR hsa-miR-139-5p Gastric cancer MNDR-E-MI-13105
MNDR hsa-miR-139-5p Gastric lymphoma MNDR-E-MI-13106
MNDR hsa-miR-139-5p Alzheimer disease MNDR-E-MI-13107
MNDR hsa-miR-139-5p Intracranial aneurysm MNDR-E-MI-13108
MNDR hsa-miR-139-5p Bladder cancer MNDR-E-MI-13109
MNDR hsa-miR-139-5p Esophageal carcinoma MNDR-E-MI-13110
MNDR hsa-miR-139-5p Dysautonomia familial MNDR-E-MI-13111
MNDR hsa-miR-139-5p Head and neck cancer MNDR-E-MI-13112
MNDR hsa-miR-139-5p Primary biliary cirrhosis MNDR-E-MI-13113
MNDR hsa-miR-139-5p Huntington disease MNDR-E-MI-13114
MNDR hsa-miR-139-5p Chorea MNDR-E-MI-13115
MNDR hsa-miR-139-5p Cardiovascular disease MNDR-E-MI-13116
MNDR hsa-miR-139-5p Carotid stenosis MNDR-E-MI-13117
MNDR hsa-miR-139-5p Uterine fibroid MNDR-E-MI-13118
MNDR hsa-miR-139-5p Lung cancer MNDR-E-MI-13119
MNDR hsa-miR-139-5p Endometrial cancer MNDR-E-MI-13120
MNDR hsa-miR-139-5p Down syndrome MNDR-E-MI-13121
MNDR hsa-miR-139-5p Parkinson disease MNDR-E-MI-13122
MNDR hsa-miR-139-5p Basal-like breast cancer MNDR-E-MI-13123
MNDR hsa-miR-139-5p Neuroendocrine neoplasia MNDR-E-MI-13124
MNDR hsa-miR-139-5p Pituitary neoplasms MNDR-E-MI-13125
MNDR hsa-miR-139-5p Pancreatic cancer MNDR-E-MI-13126
MNDR hsa-miR-139-5p Melanoma MNDR-E-MI-13127
MNDR hsa-miR-139-5p Rectum adenocarcinoma MNDR-E-MI-13128
MNDR hsa-miR-139-5p Nephroblastoma MNDR-E-MI-13129
MNDR hsa-miR-139-5p Colon cancer MNDR-E-MI-13130
MNDR hsa-miR-139-5p Colon adenocarcinoma MNDR-E-MI-13131
MNDR hsa-miR-139-5p Familial ovarian cancer MNDR-E-MI-13132
MNDR hsa-miR-139-5p Basal cell carcinoma MNDR-E-MI-13133
MNDR hsa-miR-139-5p Prostate adenocarcinoma MNDR-E-MI-13134
MNDR hsa-miR-139-5p Carcinoma ductal breast MNDR-E-MI-13135
MNDR hsa-miR-139-5p Glioblastoma MNDR-E-MI-13136
MNDR hsa-miR-139-5p Astrocytoma MNDR-E-MI-13137
MNDR hsa-miR-139-5p Glioma MNDR-E-MI-13138
MNDR hsa-miR-139-5p Oligodendroglioma MNDR-E-MI-13139
MNDR hsa-miR-139-5p Amyotrophic lateral sclerosis MNDR-E-MI-13140
MNDR hsa-miR-139-5p Osteosarcoma MNDR-E-MI-13141
MNDR hsa-miR-139-5p Breast carcinoma MNDR-E-MI-13142
MNDR hsa-miR-139-5p Middle cerebral artery infarction MNDR-E-MI-13143
MNDR hsa-miR-139-5p Uterine cancer MNDR-E-MI-13144
MNDR hsa-miR-139-5p Gastric adenocarcinoma MNDR-E-MI-13145
MNDR hsa-miR-139-5p Cervical squamous cell carcinoma MNDR-E-MI-13146
MNDR hsa-miR-139-5p Pituitary adenoma MNDR-E-MI-13147
MNDR hsa-miR-139-5p Lung squamous cell carcinoma MNDR-E-MI-13148
MNDR hsa-miR-139-5p Carcinoma lung non-small-cell MNDR-E-MI-13149
MNDR hsa-miR-139-5p Lung adenocarcinoma MNDR-E-MI-13150
MNDR hsa-miR-139-5p Adrenocortical carcinoma MNDR-E-MI-13151
MNDR hsa-miR-139-5p Adrenal cortical carcinoma MNDR-E-MI-13152
MNDR hsa-miR-139-5p Thyroid carcinoma MNDR-E-MI-13153
MNDR hsa-miR-139-5p Bladder urothelial carcinoma MNDR-E-MI-13154
MNDR hsa-miR-139-5p Pancreatic adenocarcinoma MNDR-E-MI-13155
MNDR hsa-miR-139-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-13156
MNDR hsa-miR-139-5p Kidney renal clear cell carcinoma MNDR-E-MI-13157
MNDR hsa-miR-139-5p Kidney renal papillary cell carcinoma MNDR-E-MI-13158
MNDR hsa-miR-139-5p Clear cell renal cell carcinoma MNDR-E-MI-13159
MNDR hsa-miR-139-5p Allergic rhinitis MNDR-E-MI-13160
MNDR hsa-miR-139-5p Large cell carcinoma MNDR-E-MI-13161
MNDR hsa-miR-139-5p Cholangiocarcinoma MNDR-E-MI-13162
MNDR hsa-miR-139-5p Gallbladder carcinoma MNDR-E-MI-13163
MNDR hsa-miR-139-5p Esophageal cancer MNDR-E-MI-13164
MNDR hsa-miR-139-5p Liver cirrhosis MNDR-E-MI-13165
MNDR hsa-miR-139-5p Lung small cell carcinoma MNDR-E-MI-13166
MNDR hsa-miR-139-5p Head and neck squamous cell carcinoma MNDR-E-MI-13167
MNDR hsa-miR-139-5p Breast invasive carcinoma MNDR-E-MI-13168
MNDR hsa-miR-139-5p Early hepatocellular carcinoma MNDR-E-MI-13169
MNDR hsa-miR-139-5p Familiar ovarian carcinoma MNDR-E-MI-13170
MNDR hsa-miR-139-5p B-cell lymphoma MNDR-E-MI-13171
MNDR hsa-miR-139-5p Rheumatoid arthritis MNDR-E-MI-13172
MNDR hsa-miR-139-5p T-cell leukemia MNDR-E-MI-13173
MNDR hsa-miR-139-5p Malignant pleural mesothelioma MNDR-E-MI-13174
MNDR hsa-miR-139-5p Barrett's adenocarcinoma MNDR-E-MI-13175
MNDR hsa-miR-139-5p Chronic myeloid leukemia MNDR-E-MI-13176
MNDR hsa-miR-139-5p Hodgkin lymphoma MNDR-E-MI-13177
MNDR hsa-miR-139-5p Burkitt lymphoma MNDR-E-MI-13178
MNDR hsa-miR-139-5p Neuromyelitis optica MNDR-E-MI-13179
MNDR hsa-miR-139-5p Skin cutaneous melanoma MNDR-E-MI-13180
MNDR hsa-miR-139-5p Skin melanoma MNDR-E-MI-13181
MNDR hsa-miR-139-5p Acute myelogenous leukemia MNDR-E-MI-13182
MNDR hsa-miR-139-5p Colorectal cancer MNDR-E-MI-13183
MNDR hsa-miR-139-5p Nasopharyngeal carcinoma MNDR-E-MI-13184
MNDR hsa-miR-139-5p Ependymoma MNDR-E-MI-13185
MNDR hsa-miR-139-5p Cardiomegaly MNDR-E-MI-13186
MNDR hsa-miR-139-5p Prostatic neoplasms MNDR-E-MI-13187
MNDR hsa-miR-139-5p Sleep deprivation MNDR-E-MI-13188
MNDR hsa-miR-139-5p Cerebral hemorrhage traumatic MNDR-E-MI-13189
MNDR hsa-miR-139-5p Barrett's carcinogenesis MNDR-E-MI-13190
MNDR hsa-miR-139-5p Breast cancer her3+ negative MNDR-E-MI-13191
MNDR hsa-miR-139-5p Cardiac fibrosis MNDR-E-MI-13192
MNDR hsa-miR-139-5p Duke A MNDR-E-MI-13193
MNDR hsa-miR-139-5p Low grade dysplastic nodule MNDR-E-MI-13194
MNDR hsa-miR-139-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-13195
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACTC1 Homo sapiens RR00037075
TOP